biggios-bar-opening

Precision for Medicine et Akoya : un événement de réseautage exclusif

Soirée SITC : Se détendre et se connecter

8 novembre 2024 | 18-22 pm CT

Biggio's Sports Bar, 2e étage | Houston, TX

Rejoignez-nous pour une soirée spéciale de réseautage, de cocktails et de divertissement après la SITC.

Réseautez avec d'autres leaders de l'industrie biotechnologique
Dégustez des hors-d'œuvre et des rafraîchissements gratuits.
Groovez sur les rythmes endiablés de notre DJ en direct.
Emplacement privilégié : à l'intérieur du Marriott Marquis, directement relié au centre de convention.

Présentation de l'équipe dirigeante de PFM

Chad Clark

President and Chief Operating Officer, Precision Medicine Group
Harpreet Singh, MD

Chief Medical Officer
Matt Arnold

President, Translational Sciences
Darren Davis, PhD

Senior Vice President, Translational Sciences
Amanda Woodrooffe, PhD

Senior Vice President, General Manager UK Labs

Chad_Clark_Resize

Chad Clark

President and Chief Operating Officer, Precision Medicine Group

Recognized industry leader with deep expertise spanning biomarker-driven clinical development, patient access and global market access. In addition to the role at Precision Medicine Group, Chad is also President of Precision for Medicine. In prior roles he has served as Chief Operating Officer of United BioSource Corporation and founder of DataPhaseIV. Proven ability to scale operations in response to client needs, adding the end-to-end capabilities necessary to support development and patient access to today’s complex therapies.

Harpreet-Singh2

Harpreet Singh, MD

Chief Medical Officer

Industry-leading oncologist and demonstrated medical leader in precision medicine, novel trial design and innovative regulatory initiatives designed to expedite drug approvals. Draws on nearly a decade leading oncology and rare disease programs at the FDA. Former fellow at the National Cancer Institute and frequent featured speaker at ASCO and AACR. CDER technical authority on oncologic drug and biological products for thoracic and head and neck malignancies, neurologic tumors, pediatric solid tumors and rare tumors.

Matt-Arnold-1

Matt Arnold

President, Translational Sciences

Strategic, highly collaborative biotechnology industry veteran, driven by opportunities to bring life-changing therapeutics to patients. Over two decades of global, cross-functional biotech and pharmaceutical experience, across both rapid growth and mature organizations, including leadership positions at AVROBIO, AstraZeneca, and Amgen.

Darren Davis

Darren Davis, PhD

Senior Vice President, Translational Sciences

Visionary leader with decades of distinguished biotechnology and clinical translational research experience. Founded ApoCell in 2004 and later was instrumental in developing and commercializing the ApoStream® rare-cell liquid biopsy technology. Globally recognized cancer researcher and the author of more than 100 peer-reviewed publications. Dedicated and committed to improving the lives of patients with debilitating diseases.

Amanda Woodroofe

Amanda Woodrooffe, PhD

Senior Vice President, General Manager UK Labs

Experienced leader of scientific operations for drug discovery in both the pharmaceutical and CRO industries. Driven to provide actionable data enabling biopharmaceutical research and development. Collaborative partner ensuring licensing and scientific support for corporate development initiatives.